# Step 2 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients

> **NCT05782894** · PHASE3 · COMPLETED · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 164 (actual)

## Conditions studied

- Sedative
- Mechanical Ventilation

## Interventions

- **DRUG:** Remimazolam besylate
- **DRUG:** Propofol
- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT05782894
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-28
- **Primary completion:** 2023-11-25
- **Final completion:** 2023-11-25
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2024-01-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05782894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05782894, "Step 2 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT05782894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*